Answers are grounded in this paper and cite their sources.
OBJECTIVE: ) underlying early-onset Charcot-Marie-Tooth (CMT) disease. METHODS: . Quantitative PCR, protein analytics, immunocytochemistry, electron microscopy, and single-cell transcriptomics were used to investigate patient and control neurons. RESULTS: mRNA. CONCLUSIONS: nonsense mutations. Here, we show that such mutation leads to the absence of NEFL, causing childhood-onset neuropathy through a loss-of-function mechanism. We propose that the neurofilament accumulation, a common feature of many neurodegenerative diseases, mimics the absence of NEFL seen in recessive CMT if aggregation prevents the proper localization of wild-type NEFL in neurons. Our results suggest that the removal of NEFL as a proposed treatment option is harmful in humans.
No takes yet. Share an insight, caveat, or question.
Sainio et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: